Fulminant hepatitis | Causes | Pathophysiology | Signs and symptoms | Treatment | Nursing Management

Fulminant hepatitis, also known as acute liver failure, is a rare but severe form of liver injury characterized by rapid and massive hepatocellular necrosis leading to acute liver dysfunction. Unlike chronic liver diseases, fulminant hepatitis typically develops over a short period, often within days to weeks, and can progress rapidly to hepatic encephalopathy, multi-organ failure, and death without prompt intervention.

Causes of Fulminant Hepatitis

Fulminant hepatitis, or acute liver failure, can be triggered by various factors and underlying conditions. Common causes include:

  • Viral Hepatitis: Certain viruses, such as hepatitis A, B, and E viruses, can cause acute liver failure. Hepatitis B and hepatitis E are particularly associated with severe liver injury and fulminant hepatitis.
  • Drug-Induced Liver Injury: Exposure to hepatotoxic substances, including prescription medications, over-the-counter drugs, herbal supplements, and recreational drugs, can lead to acute liver failure. Examples of hepatotoxic drugs include acetaminophen (paracetamol), certain antibiotics, anticonvulsants, and chemotherapeutic agents.
  • Toxic Chemicals and Environmental Exposures: Ingestion or inhalation of toxic chemicals, such as industrial solvents, pesticides, and household cleaners, can cause acute liver failure. Occupational exposures and environmental contaminants may also contribute to liver injury and fulminant hepatitis.
  • Autoimmune Hepatitis: Autoimmune hepatitis is a chronic inflammatory liver disease characterized by immune-mediated destruction of hepatocytes. In some cases, autoimmune hepatitis can present as acute liver failure, especially during disease flares or in individuals with rapid disease progression.
  • Metabolic Disorders: Metabolic disorders, such as Wilson’s disease, acute fatty liver of pregnancy, and acute liver failure in the setting of acute alcoholic hepatitis, can result in fulminant hepatitis. These conditions disrupt normal liver function and metabolism, leading to acute liver failure.
  • Ischemic Hepatitis: Ischemic hepatitis, also known as shock liver, occurs due to inadequate blood flow to the liver, often secondary to severe systemic hypotension, shock, or cardiac arrest. The ischemic insult causes rapid hepatocellular injury and can progress to acute liver failure if left untreated.
  • Vascular Disorders: Certain vascular disorders affecting the liver, such as Budd-Chiari syndrome (hepatic vein thrombosis) or portal vein thrombosis, can lead to acute liver failure by impairing blood flow and causing ischemic injury to hepatocytes.
  • Infections: Infections other than viral hepatitis, such as acute bacterial or fungal infections, can rarely lead to acute liver failure, particularly in individuals with underlying liver disease or compromised immune function.

Pathophysiology

Following the introduction of a causative agent into the body, such as toxins or certain viral infections, a cascade of events unfolds within the liver, initiating an acute inflammatory response. This inflammatory reaction triggers hepatic vascular occlusion, resulting in reduced blood flow to the liver and subsequent ischemia and hypoxia of hepatic tissue. Ischemia, characterized by inadequate blood supply, sets the stage for the progression of hepatocellular injury and necrosis, as vital oxygen and nutrients are deprived from hepatocytes, the functional cells of the liver.

The ischemic insult leads to widespread damage and death of hepatocytes, culminating in hepatic necrosis. As the liver tissue undergoes necrosis, it releases pro-inflammatory cytokines and other toxic substances into the bloodstream, exacerbating the inflammatory response and further compromising liver function. This cascade of events not only disrupts the liver’s ability to perform its vital functions, such as detoxification and metabolism, but also contributes to the development of hepatic encephalopathy, a serious complication characterized by altered mental status and cognitive impairment.

Despite advancements in medical care and supportive therapy, fulminant hepatitis remains a life-threatening condition with a remarkably high mortality rate ranging from 60% to 85%. Even with intensive treatment measures aimed at stabilizing the patient, managing complications, and supporting liver function, many individuals with fulminant hepatitis fail to survive. The rapid and severe nature of the liver injury, combined with the challenges of managing complications such as hepatic encephalopathy and multi-organ dysfunction, underscores the urgent need for early recognition, prompt intervention, and aggressive management strategies in the care of patients with this devastating condition.

Signs and Symptoms

  • Jaundice: Jaundice, characterized by yellowing of the skin and sclerae, occurs due to the accumulation of bilirubin in the bloodstream as a result of impaired liver function.
  • Frothy Urine: Urine may become frothy when shaken, indicating the presence of proteinuria, a common finding in patients with fulminant hepatitis due to renal dysfunction.
  • Pruritus: Pruritus, or itching, may occur as bile salts accumulate in the skin due to impaired excretion, causing irritation and discomfort.
  • Steatorrhea and Diarrhea: Poor absorption of fats and nutrients in the gastrointestinal tract can lead to steatorrhea (fatty stools) and diarrhea, contributing to malnutrition and weight loss.
  • Peripheral Edema: Peripheral edema, characterized by swelling of the extremities, may develop due to hypoalbuminemia and decreased oncotic pressure, leading to fluid accumulation in interstitial spaces.
  • Ascites: Ascites, the accumulation of fluid in the peritoneal cavity, is a common complication of fulminant hepatitis, resulting from portal hypertension secondary to liver dysfunction.
  • Bleeding Tendencies: Coagulopathy, manifested by easy bruising, petechiae, or mucosal bleeding, can occur due to impaired synthesis of clotting factors and decreased production of proteins by the damaged liver.
  • Altered Mental Status: Patients may experience irritability, confusion, or coma as hepatic encephalopathy develops, resulting from the accumulation of toxic substances, such as ammonia, in the bloodstream due to impaired liver clearance.
  • Fever: Fever may be present in some cases of fulminant hepatitis, especially if there is an underlying infectious etiology or systemic inflammatory response.
  • Hepatic Coma: Hepatic coma, a severe manifestation of hepatic encephalopathy, is characterized by profound alterations in consciousness, ranging from confusion to coma, and requires urgent medical attention.

Management

History:

Medical History:

  • Obtain a detailed medical history, including past medical conditions, medications, and previous episodes of liver disease.
  • Inquire about potential risk factors for hepatitis, such as intravenous drug use, unprotected sexual activity, recent travel to endemic regions, or occupational exposures to hepatotoxic substances.

Symptom Assessment:

  • Ask about the onset and duration of symptoms, including jaundice, abdominal pain, nausea, vomiting, fatigue, and changes in mental status.
  • Inquire about associated symptoms such as pruritus, diarrhea, dark urine, and pale stools, which may suggest liver dysfunction or complications of fulminant hepatitis.

Exposure History:

  • Assess for potential exposure to infectious agents, toxic chemicals, herbal supplements, or medications known to cause liver injury.
  • Determine the patient’s alcohol consumption history, as excessive alcohol intake can exacerbate liver damage and contribute to the development of fulminant hepatitis.

Family History:

  • Inquire about a family history of liver disease, autoimmune disorders, or hereditary conditions that may predispose to liver dysfunction, such as Wilson’s disease or hemochromatosis.

Physical Examination:

General Examination:

  • Assess the patient’s vital signs, including temperature, blood pressure, heart rate, and respiratory rate, to evaluate for signs of systemic illness or hemodynamic instability.
  • Evaluate the patient’s general appearance, noting signs of jaundice, pallor, or cachexia suggestive of underlying liver disease.

Abdominal Examination:

  • Palpate the abdomen to assess for hepatomegaly, splenomegaly, or tenderness, which may indicate liver inflammation, congestion, or enlargement.
  • Percuss for the presence of ascites, eliciting shifting dullness or a fluid wave, suggestive of fluid accumulation in the peritoneal cavity.

Skin and Mucosal Examination:

  • Inspect the skin and sclerae for signs of jaundice, characterized by yellow discoloration, and assess for evidence of pruritus, ecchymoses, or petechiae suggestive of coagulopathy.
  • Examine mucous membranes for signs of bleeding or mucosal lesions, which may indicate underlying liver dysfunction or systemic complications.

Neurological Examination:

  • Perform a focused neurological assessment, including mental status evaluation, orientation, cognitive function, and assessment of motor and sensory function, to screen for hepatic encephalopathy or neurological complications.

Laboratory Investigations:

  • Order laboratory tests, including liver function tests (serum transaminases, bilirubin, albumin, and coagulation profile), a complete blood count, renal function tests, and viral serology (for hepatitis viruses), to assess liver function, detect metabolic abnormalities, and identify potential infectious etiologies.

Imaging Studies:

  • Consider abdominal ultrasound or computed tomography (CT) imaging to evaluate liver morphology, assess for the presence of hepatic lesions or vascular abnormalities, and detect signs of portal hypertension or ascites.

Additional Investigations:

  • Depending on the clinical presentation and suspected etiology, additional investigations such as viral serology, autoimmune markers, toxicology screening, or liver biopsy may be indicated to confirm the diagnosis and guide management decisions.

Diagnosis 

Liver Function Tests (LFTs):

  • Liver function tests, including serum levels of transaminases (such as alanine aminotransferase [ALT] and aspartate aminotransferase [AST]), bilirubin, alkaline phosphatase, and albumin, are essential for assessing the degree of liver dysfunction and determining the severity of hepatic injury.

Electroencephalogram (EEG) for Encephalopathy:

  • An EEG may be performed to evaluate for the presence of hepatic encephalopathy, a common complication of fulminant hepatitis characterized by alterations in brain electrical activity. EEG findings can help confirm the diagnosis and guide treatment decisions.

Toxicology Screening:

  • Toxicology screening involves testing for the presence of toxic substances, drugs, or medications that may contribute to liver injury or exacerbate fulminant hepatitis. Identifying and eliminating hepatotoxic agents is crucial for preventing further liver damage and optimizing patient management.

Viral Markers and Autoantibodies:

  • Serological testing for viral markers, including hepatitis A, B, and C viruses, as well as autoantibodies associated with autoimmune hepatitis (such as anti-nuclear antibodies [ANA], anti-smooth muscle antibodies [ASMA], and anti-liver/kidney microsomal antibodies [LKM]), helps identify the underlying etiology of fulminant hepatitis and guide specific treatment strategies.
  • Additionally, testing for serum and urinary copper levels may be indicated to evaluate Wilson’s disease, a rare inherited disorder characterized by abnormal copper metabolism and hepatic copper accumulation.

Abdominal Ultrasound:

  • Abdominal ultrasound imaging is a non-invasive diagnostic tool used to evaluate liver morphology, assess for the presence of hepatic lesions or masses, and detect signs of portal hypertension, ascites, or biliary obstruction. Ultrasound findings may provide valuable information about the underlying pathology and guide further diagnostic and therapeutic interventions.

Imaging Studies:

  • In addition to abdominal ultrasound, other imaging modalities, such as computed tomography (CT) scans or magnetic resonance imaging (MRI), may be performed to further characterize liver anatomy, assess for complications such as hepatic abscesses or portal vein thrombosis, and guide treatment planning.

Liver biopsy (if indicated):

  • In certain cases, a liver biopsy may be warranted to obtain histopathological confirmation of the diagnosis, assess the degree of liver inflammation and fibrosis, and rule out other causes of liver injury. However, liver biopsy is not routinely performed in all cases of fulminant hepatitis and should be reserved for selected patients based on clinical judgment and individualized risk-benefit considerations.

Treatment 

Potassium-Sparing Diuretics:

  • Administration of potassium-sparing diuretics, such as spironolactone (100mg orally per day), helps reduce edema while conserving potassium for essential cellular metabolism.

Management of Cerebral Edema:

  • Cerebral edema is managed by administering mannitol, an osmotic diuretic that helps reduce intracranial pressure and alleviate symptoms of hepatic encephalopathy.

Nutritional Support:

  • Vitamin supplementation, including vitamin A, vitamin B complex (1 tablet daily), vitamin C, and vitamin K, is provided to improve the integrity of mucous membranes in the gastrointestinal tract and enhance prothrombin levels for effective blood coagulation.

Antibiotic Therapy:

  • Antibiotics such as amoxicillin may be prescribed to treat suspected bacterial infections, particularly in cases of fulminant hepatitis associated with bacterial translocation and systemic inflammation.

Abdominal Paracentesis:

  • Abdominal paracentesis is performed to remove ascitic fluid in cases of significant ascites, relieving abdominal discomfort and respiratory compromise associated with fluid accumulation in the peritoneal cavity.

Gastrointestinal Protection:

  • Anti-acid medications and H2-receptor antagonists, such as magnesium trisilicate, are administered to reduce the risk of gastrointestinal bleeding from stress ulcers, a common complication in critically ill patients with fulminant hepatitis.

Liver Transplantation:

  • Liver transplantation is considered the treatment of choice for eligible patients with fulminant hepatitis, offering the best chance for long-term survival and resolution of liver failure.

Steroid Therapy:

  • Steroids, such as prednisolone, may be used as adjunctive therapy to reduce inflammation and modulate the immune response in selected cases of fulminant hepatitis, particularly those with autoimmune etiologies.

Intravenous 10% Dextrose:

  • Intravenous administration of 10% dextrose solution is provided to maintain adequate glucose levels and prevent hypoglycemia, which can exacerbate hepatic encephalopathy and metabolic derangements in patients with fulminant hepatitis.

Nursing Management

Objectives

  • To prevent the transmission of the infection to others.
  • To enhance liver function and minimize the risk of complications.
  • To educate the patient about the nature and management of the condition.

Environmental Management:

  • Isolation Precautions: Implement isolation protocols to prevent the spread of infection to other individuals. This includes limiting contact with healthcare staff and other patients, as well as using personal protective equipment as necessary.
  • Ventilation: Ensure adequate ventilation in the patient’s room to reduce the risk of respiratory tract infections. Dust can harbor pathogens and irritate the respiratory tract, so maintaining a clean and well-ventilated environment is essential.
  • Lighting: Ensure the patient’s room is well-lit to facilitate easy observation and orientation to time and place. Adequate lighting can also contribute to a sense of comfort and well-being for the patient.
  • Accessibility of Equipment: Arrange all necessary equipment within reach of the patient for easy access if needed. This includes medical devices, emergency call buttons, and personal items to promote independence and convenience.

Positioning:

  • Fowler’s Position: Position the patient in Fowler’s position to facilitate lung expansion and alleviate dyspnea. This semi-upright position can improve respiratory function and oxygenation.
  • Regular Position Changes: Change the patient’s position every two hours to prevent the development of pressure ulcers. Regular repositioning helps relieve pressure on vulnerable areas of the body and promotes circulation.
  • Comfortable Positioning: As the patient’s condition improves, allow them to adopt positions of comfort to promote rest and relaxation. Encourage the patient to find a comfortable position that supports their recovery and enhances their overall well-being.

Rest Promotion:

  • Quiet Environment: Ensure the patient is in a noise-free environment to facilitate rest and relaxation. Minimize unnecessary noise and disturbances in the patient’s surroundings.
  • Coordinated Procedures: Perform related procedures together to avoid interrupting the patient’s periods of rest. Coordinate nursing tasks and medical interventions to minimize disruptions to the patient’s sleep and rest schedule.
  • Pain Management: Administer prescribed analgesics as needed to alleviate pain and discomfort, promoting rest and sleep. Effective pain management can enhance the patient’s ability to rest and recover.
  • Maintenance of Equipment: Ensure that equipment such as trolleys are well-oiled to prevent squeaking noises that may disrupt the patient’s rest. A quiet environment promotes relaxation and supports restful sleep.

Observations:

  • Vital Signs Monitoring: Regularly monitor vital signs including temperature, pulse, blood pressure, and respirations to establish baseline data and detect any changes indicative of improvement or deterioration in the patient’s condition.
  • Edema Observation: Monitor for signs of edema and assess whether it is improving or worsening. Elevate the foot end of the bed to promote venous drainage and reduce swelling if necessary.
  • Itching Management: Assess for itching and provide antihistamines as appropriate to relieve discomfort and promote rest. Itching can interfere with sleep and rest, so effective management is essential.
  • Pressure Ulcer Assessment: Assess pressure areas regularly to detect the onset of pressure sores. Reposition the patient regularly to relieve pressure and prevent skin breakdown.
  • Stool and Urine Observation: Observe the color and characteristics of stool and urine to assess for any improvements towards normal. Changes in stool and urine output may indicate changes in the patient’s condition that require further evaluation.

Psychological Care:

  • Education on Disease Process: Explain the disease process to the patient in a clear and understandable manner to increase their understanding and reduce anxiety. Encourage questions and provide thorough answers. If unable to address concerns, refer the patient to appropriate healthcare team members for further clarification.
  • Procedure Explanation: Explain all procedures to the patient to alleviate anxiety. Providing information about what to expect during medical interventions can help reduce fear and uncertainty.
  • Peer Support: Arrange for a successfully managed case to speak with the patient, sharing their experiences and offering encouragement. This interaction can dispel misconceptions, instill hope, and provide reassurance.
  • Isolation Reasoning: Explain the rationale for isolation measures to the patient to alleviate anxiety. Assure them that these precautions are in place to protect their health and prevent the spread of infection to others.
  • Diversional Therapy: Provide diversional activities to distract the patient from hospital routines and their condition. Engaging in enjoyable activities can improve mood and promote relaxation.
  • Patient Involvement in Care Planning: Involve the patient in planning their own care to promote a sense of control, self-esteem, and cooperation. Encourage their active participation in decision-making regarding treatment options and daily care routines.

Hygiene:

  • Assistance with Bathing: Assist the patient with bathing to remove dead skin cells and promote comfort. Bathing also helps maintain skin hygiene and prevent infections.
  • Hair Care: Provide hair care to promote self-esteem and prevent infestations such as pediculosis. Clean and well-groomed hair can boost the patient’s morale and overall well-being.
  • Nail Care: Perform nail care to prevent autoinfection and maintain hygiene. Proper nail hygiene reduces the risk of bacterial or fungal infections and supports overall health.
  • Mouth Care: Assist with mouth care to prevent halitosis (bad breath) and promote oral hygiene. Regular oral care helps prevent dental problems, maintain oral health, and stimulate appetite.
  • Linen and Clothing Change: Ensure that any soiled linen and clothing are promptly changed to promote comfort and hygiene. Clean and fresh linens contribute to a comfortable and sanitary environment for the patient.

Elimination:

  • Fluid and Roughage Intake: Encourage the patient to consume plenty of fluids and foods high in roughage to prevent constipation. Adequate hydration and fiber intake support regular bowel movements and prevent complications such as fecal impaction.
  • Renal Health Promotion: Emphasize the importance of fluid intake to prevent renal problems and facilitate the elimination of toxins from the body. Proper hydration supports kidney function and helps maintain urinary tract health.
  • Bedpan Use: Offer a bedpan to the patient if they are confined to bed to ensure timely bowel movements and maintain comfort. Proper positioning and assistance with toileting can prevent discomfort and complications related to immobility.
  • Infection Prevention during Disposal: Utilize infection prevention techniques when disposing of the patient’s excreta to minimize the risk of cross-infection and further spread of pathogens. Disinfect feces and vomitus before disposal to prevent contamination of the environment.

Nutrition:

  • Nutritious and Appetizing Diet: Provide a diet that is both nutritious and appetizing to the patient. Offer small, frequent feedings to support energy levels and prevent malnutrition.
  • Dietary Components: Include carbohydrates such as grains (e.g., nshima) for energy, proteins from sources like beans and fish for tissue repair, and vitamins from vegetables and fruits to boost immunity and maintain skin and mucous membrane integrity.
  • IV Fluids for Vomiting: If the patient is vomiting, administer intravenous fluids rich in electrolytes and glucose to prevent dehydration and maintain hydration status. Monitor intake and output to prevent renal failure and fluid overload.
  • Meal Environment: Serve meals in pleasant surroundings to stimulate the patient’s appetite and enhance the dining experience. A comfortable and inviting meal environment can improve food intake and overall nutritional status.
  • Weight Monitoring: Regularly monitor the patient’s weight using the same scale, at the same time of day, and with the same clothing to track changes and detect weight loss secondary to poor appetite.
  • Fat Restriction: Avoid fatty foods until the patient is able to tolerate them, as high-fat foods may exacerbate gastrointestinal symptoms and discomfort. Gradually reintroduce fat into the diet as tolerated by the patient.

Exercises:

  • Passive Limb Exercises: If the patient is bedridden, assist them in performing passive limb exercises and gentle massage to prevent muscle atrophy and improve blood circulation. These exercises help maintain joint flexibility and prevent stiffness.
  • Deep Breathing Exercises: Encourage the patient to engage in deep breathing exercises to promote lung expansion and improve respiratory function. Deep breathing helps prevent atelectasis (collapse of lung tissue) and enhances oxygenation.
  • Early Ambulation: Encourage early ambulation as soon as the patient’s condition permits to prevent complications of immobility such as deep vein thrombosis (DVT). Gradual mobilization helps maintain muscle strength, joint mobility, and overall physical function.

Medication:

  • Timely Administration of Prescribed Drugs: Administer prescribed medications at the scheduled times to ensure optimal therapeutic effects and promote quick recovery. Adhering to the medication regimen as prescribed by the healthcare provider is essential for effective treatment.
  • Monitoring for Side Effects: Monitor the patient for any potential side effects or adverse reactions to the prescribed medications. Promptly report any concerning symptoms to the healthcare team for further evaluation and management. Regular monitoring helps ensure patient safety and treatment effectiveness.

Health Education:

  • Good Personal Hygiene: Instruct the patient to practice good personal hygiene, including regular bathing, oral hygiene, and clean clothing, to prevent the spread of infections.
  • Handwashing Importance: Stress the importance of washing hands frequently, especially before eating and after using the bathroom, to reduce the risk of contracting and spreading infections.
  • Sanitation Practices: Encourage the adoption of optimal sanitation practices, such as proper waste disposal and clean water sources, to prevent the transmission of infectious diseases.
  • Blood Safety Measures: Implement proper safeguards to prevent the use of blood and its components from infected donors, ensuring safe transfusions and medical procedures.
  • Food Handler Screening: Screen food handlers carefully to prevent foodborne illnesses. Emphasize safe food preparation and serving techniques to reduce the risk of contamination.
  • Disease Awareness: Educate the patient about their condition to increase awareness and prevent recurrence. Provide information on symptoms, treatment options, and preventive measures.
  • Drug Compliance: Explain the importance of adhering to prescribed medications to prevent drug resistance and ensure effective treatment outcomes.
  • Early Diagnosis Awareness: Educate the patient about the signs and symptoms of their condition for early diagnosis and prompt treatment. Prompt recognition of symptoms can lead to a better prognosis and recovery.
  • Monitoring Progress: Advise the patient to keep track of review dates to monitor their progress and ensure full recovery. Regular follow-up appointments are essential for monitoring treatment responses and addressing any concerns.
  • Avoiding Overcrowding: Advise the patient to avoid overcrowded environments to reduce the risk of infection transmission, especially for contagious diseases.
  • Balanced Diet: Explain the importance of a balanced diet using locally available foods to boost immunity, provide energy, and promote tissue healing. Emphasize the consumption of nutritious foods rich in vitamins and minerals.
  • Alcohol Avoidance: Encourage the patient to abstain from alcohol consumption, as it can worsen liver conditions and interfere with treatment effectiveness.
  • Safe Sexual Practices: Advise the patient to avoid unprotected sexual intercourse until they test negative for antibodies to prevent reinfection and transmission of sexually transmitted infections.
  • Rest Importance: Stress the importance of rest for overall health and recovery. Adequate rest allows the body to repair and regenerate, supporting the healing process.

Complications of Hepatitis

  • Liver Failure: Occurs due to sudden and extensive destruction of liver cells, leading to impaired liver function and potentially life-threatening complications.
  • Chronic Hepatitis: Results from untreated or recurrent episodes of hepatitis, leading to ongoing inflammation and damage to the liver over time. Chronic hepatitis can progress to more severe liver conditions if left untreated.
  • Hepatic Coma: This occurs when toxins build up in the bloodstream and invade brain cells, leading to neurological dysfunction and altered consciousness. Hepatic coma is a serious complication of advanced liver disease.
  • Liver Cirrhosis: develops as a result of extensive degeneration and destruction of liver parenchymal cells, leading to the formation of scar tissue. Cirrhosis disrupts liver function and can progress to liver failure if left untreated.
  • Liver Cancer: Chronic inflammation of hepatocytes, caused by recurrent cycles of cell death and regeneration, can lead to preneoplastic changes such as hepatocyte dysplasia, increasing the risk of liver cancer.
  • Encephalopathy: A neuropsychiatric complication of liver damage, encephalopathy occurs due to the accumulation of nitrogenous waste products in the bloodstream, leading to brain dysfunction. Symptoms include apathy, disorientation, muscular rigidity, delirium, and coma. Encephalopathy is a terminal complication of advanced liver disease and requires prompt medical intervention.

Read more: Medical-Surgical Nursing

Read more: Hepatitis C (HCV) | Pathophysiology | Signs and symptoms | Treatment | Nursing Management

Facebook
Twitter
LinkedIn
WhatsApp

Recent Posts

Contact Form